Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies-Reference-Cited by-同舟云学术

Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies

Published:2019-12-02 Issue:12 Volume:17 Page:917-927
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Santoni Matteo¹,Conti Alessandro²,Massari Francesco³,Di Nunno Vincenzo³,Faloppi Luca¹,Galizia Eva¹,Morbiducci Jarno⁴,Piva Francesco⁵,Buti Sebastiano⁶^ORCID,Iacovelli Roberto⁷,Ferretti Benedetta⁸,Cimadamore Alessia⁹,Scarpelli Marina⁹,Lopez-Beltran Antonio¹⁰,Cheng Liang¹¹,Battelli Nicola¹,Montironi Rodolfo⁹

Affiliation:

1. Oncology Unit, Macerata Hospital, Macerata, Italy

2. Azienda Ospedaliera dell’Alto Adige, Bressanone/Brixen Hospital, Bressanone, Italy

3. Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

4. Department of Radiodiagnosis, Area Vasta n°3, Macerata, Italy

5. Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy

6. Division of Oncology, University Hospital of Parma, Parma, Italy

7. Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata (AOUI), University of Verona, Verona, Italy

8. Oncologia Medica, Ospedale di San Severino, San Severino Marche (MC), Macerata, Italy

9. Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, Ancona, Italy

10. Department of Pathology and Surgery, Faculty of Medicine, Cordoba, Spain

11. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

Funder

funded

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2019.1704626

Reference134 articles.

1. Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma

2. Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens

3. Hypertension and breast cancer risk: a systematic review and meta-analysis

4. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies

5. Meta-analysis of metabolic syndrome and prostate cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats;Biochemical Pharmacology;2024-05

2. Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications;Drug Design, Development and Therapy;2024-03

3. Comprehensive molecular characterization of hypertension-related genes in cancer;Cardio-Oncology;2022-05-05

4. Endocrine complications of new anticancer therapies;Postępy Higieny i Medycyny Doświadczalnej;2021-03-18